PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study
Visit https://www.peervoice.com/CPF860 to view the entire programme with slides. After completing “Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study”, participants will be able to: Describe the rationale, design, and key findings of a study to identify biomarkers for patients at risk of persistent severe acute kidney injury (AKI); Explain the role of urinary CCL14 as a biomarker for stratifying patients at risk for persistent severe AKI as demonstrated in the study; and Translate the use of biomarkers for management of patients with, or at risk of, persistent severe AKI.